Dr. Robert Schwarcz, a double-board certified oculofacial plastic surgeon and facial aesthetics specialist in the Big Apple, told The Post he’s observed a “seismic shift” in his practice in the last ...

Cash and Cash Equivalents: As of September 30, 2025, Kymera had $978.7 million in cash, cash equivalents and investments. Kymera expects that its cash balance will provide the Company with a cash ...

Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell ...

New results from a study of a drug called Gazyva (obinutuzumab) showed that it significantly reduced disease activity in adults with systemic lupus erythematosus (SLE).

Kyndryl (KD) shares were active in extended trading on Tuesday after the IT infrastructure company posted second-quarter ...

UCB has scored an FDA approval for ultra-rare disease treatment Kygevvi, continuing the positive momentum for the Belgian ...

Kyle Kennedy was experiencing pain and swelling in his neck but doctors told him he had swollen glands and to take ...

Kygevvi is indicated for patients with thymidine kinase 2 deficiency whose symptoms arise by 12 years of age. The disease ...

Hirano at Columbia University, an MDA Care Center, to develop a TK2-deficient mouse model, which proved that targeted treatments could restore mitochondrial function. This led to FDA granting ...

Kymera Therapeutics, Inc. ( ($KYMR) ) has released its Q3 earnings. Here is a breakdown of the information Kymera Therapeutics, Inc. presented to ...

Discover Kymera Therapeutics' Q3 2025 earnings, clinical trial milestones in immunology, and strategic Gilead partnership.

Following actress Isabelle Tate‘s unexpected death at age 23 earlier this month, 9-1-1: Nashville paid tribute in the latest episode. Thursday’s episode “Bad Case of the Blues” ended with an “in ...